Prostate Cancer - Results from #20620

Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan - Abstract May 7, 2014

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy - Abstract May 7, 2014

Myriad and UnitedHealthcare sign three-year agreement making myRisk™ Hereditary Cancer test available to United members May 7, 2014

Astellas and Medivation receive priority review from FDA for XTANDI(R) (enzalutamide) capsules in chemotherapy-naive advanced prostate cancer May 7, 2014

Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: The Radiation Therapy Oncology Group [0831] randomized clinical trial - Abstract May 6, 2014

Gleason 6 prostate cancer: Serious malignancy or toothless lion? - Abstract May 6, 2014

External validation of the Briganti nomogram to estimate the probability of specimen confined disease in patients with high-risk prostate cancer - Abstract May 6, 2014

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: Results from a systematic review and meta-analysis - Abstract May 6, 2014

Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: A prospective study of 200 patients - Abstract May 6, 2014

Aspirin use and the risk of prostate cancer: A meta-analysis of 24 epidemiologic studies - Abstract May 6, 2014

Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer - Abstract May 6, 2014

The Prostate Health Index: A new test for the detection of prostate cancer - Abstract May 6, 2014

MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer - Abstract May 6, 2014

Is there an anti-androgen withdrawal syndrome for enzalutamide? - Abstract May 6, 2014

External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone - Abstract May 6, 2014

Factors influencing disease progression of prostate cancer under active surveillance: A McGill University Health Center Cohort - Abstract May 6, 2014

A phase II, randomized, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue in prostate cancer patients receiving LHRH-agonist therapy - Abstract May 6, 2014

Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy - Abstract May 6, 2014

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer - Abstract May 6, 2014

Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions - Abstract May 6, 2014

Page 1032 of 1436